1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma-derived Therapies Market Size Growth Rate by Type (2022-2028)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Factor VIII
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma-derived Therapies Market Share by Application (2022-2028)
1.3.2 Hemophilia
1.3.3 Primary Immunodeficiencies (PIDs)
1.3.4 Idiopathic Thrombocytopenic Purpura (ITP)
1.3.5 COVID-19
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered 2 Executive Summary
2.1 Global Plasma-derived Therapies Market Size
2.2 Plasma-derived Therapies Market Size by Regions
2.2.1 Plasma-derived Therapies Growth Rate by Regions (2022-2028)
2.2.2 Plasma-derived Therapies Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases 3 Key Players
3.1 Plasma-derived Therapies Revenue by Players (2022 & 2028)
3.2 Plasma-derived Therapies Key Players Headquarters and Area Served
3.3 Key Players Plasma-derived Therapies Product/Solution/Service
3.4 Date of Enter into Plasma-derived Therapies Market
3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application
4.1 Global Plasma-derived Therapies Market Size by Type (2022-2028)
4.2 Global Plasma-derived Therapies Market Size by Application (2022-2028) 5 North America
5.1 North America Plasma-derived Therapies Market Forecast (2022-2028)
5.2 Plasma-derived Therapies Key Players in North America
5.3 North America Plasma-derived Therapies Market Size by Type
5.4 North America Plasma-derived Therapies Market Size by Application 6 Europe
6.1 Europe Plasma-derived Therapies Market Forecast (2022-2028)
6.2 Plasma-derived Therapies Key Players in Europe
6.3 Europe Plasma-derived Therapies Market Size by Type
6.4 Europe Plasma-derived Therapies Market Size by Application 7 Asia-Pacific
7.1 Asia-Pacific Plasma-derived Therapies Market Forecast (2022-2028)
7.2 Plasma-derived Therapies Key Players in Asia-Pacific
7.3 Asia-Pacific Plasma-derived Therapies Market Size by Type
7.4 Asia-Pacific Plasma-derived Therapies Market Size by Application 8 Rest of World
8.1 Latin America
8.1.1 Latin America Plasma-derived Therapies Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Plasma-derived Therapies Market Analysis
8.2.2 Key Players in Middle East & Africa 9 International Player Profiles
9.1 CSL Behring LLC
9.1.1 CSL Behring LLC Company Details
9.1.2 CSL Behring LLC Description and Business Overview
9.1.3 CSL Behring LLC Plasma-derived Therapies Introduction
9.1.4 CSL Behring LLC Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.1.5 CSL Behring LLC Recent Development
9.2 Shire
9.2.1 Shire Company Details
9.2.2 Shire Description and Business Overview
9.2.3 Shire Plasma-derived Therapies Introduction
9.2.4 Shire Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.2.5 Shire Recent Development
9.3 Bayer
9.3.1 Bayer Company Details
9.3.2 Bayer Description and Business Overview
9.3.3 Bayer Plasma-derived Therapies Introduction
9.3.4 Bayer Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.3.5 Bayer Recent Development
9.4 Kedrion
9.4.1 Kedrion Company Details
9.4.2 Kedrion Description and Business Overview
9.4.3 Kedrion Plasma-derived Therapies Introduction
9.4.4 Kedrion Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.4.5 Kedrion Recent Development
9.5 Takeda
9.5.1 Takeda Company Details
9.5.2 Takeda Description and Business Overview
9.5.3 Takeda Plasma-derived Therapies Introduction
9.5.4 Takeda Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.5.5 Takeda Recent Development
9.6 Biotest
9.6.1 Biotest Company Details
9.6.2 Biotest Description and Business Overview
9.6.3 Biotest Plasma-derived Therapies Introduction
9.6.4 Biotest Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.6.5 Biotest Recent Development
9.7 Octaparma
9.7.1 Octaparma Company Details
9.7.2 Octaparma Description and Business Overview
9.7.3 Octaparma Plasma-derived Therapies Introduction
9.7.4 Octaparma Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.7.5 Octaparma Recent Development
9.8 Bio Products Laboratory (BPL)
9.8.1 Bio Products Laboratory (BPL) Company Details
9.8.2 Bio Products Laboratory (BPL) Description and Business Overview
9.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Introduction
9.8.4 Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.8.5 Bio Products Laboratory (BPL) Recent Development
9.9 LFB
9.9.1 LFB Company Details
9.9.2 LFB Description and Business Overview
9.9.3 LFB Plasma-derived Therapies Introduction
9.9.4 LFB Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.9.5 LFB Recent Development
9.10 Grifols
9.10.1 Grifols Company Details
9.10.2 Grifols Description and Business Overview
9.10.3 Grifols Plasma-derived Therapies Introduction
9.10.4 Grifols Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.10.5 Grifols Recent Development 10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints 11 Key Findings in This Report 12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
